Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05381454 · ClinicalTrials.gov registry record · Phase 1
An Open Label Study in Adults to Test the Efficacy of Mitoquinone/Mitoquinol Mesylate to Prevent Severe Viral Illness
A Phase 1 study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- Phase 1
- Development phase
- 80
- Enrollment target
NCT05381454 is a Phase 1 study that has completed, run by University of California, Los Angeles. The registered enrollment target is 80 participants.
The verdict
NCT05381454, a Phase 1 study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 80 participants
- Enrollment target
Study Summary
Open label clinical trial of persons (adults) that will determine the safety and efficacy of the diet supplement oral mitoquinone/mitoquinol mesylate (Mito-MES) to prevent the development and progression of severe viral infections like COVID-19 after high-risk exposure to a person with possible respiratory viral infection such as SARS-CoV-2 infection in persons who will receive Mito-MES compared to persons who will not receive Mito-MES (controls).
Interventions
- DRUG Mitoquinone/mitoquinol mesylate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2022-04-28 |
| Est. Completion | 2023-05-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05381454
The ClinicalTrials.gov registry entry for NCT05381454 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mitoquinone/mitoquinol mesylate is the first listed.
NCT05381454 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05381454 about?
NCT05381454 is a clinical study titled "An Open Label Study in Adults to Test the Efficacy of Mitoquinone/Mitoquinol Mesylate to Prevent Severe Viral Illness". Open label clinical trial of persons (adults) that will determine the safety and efficacy of the diet supplement oral mitoquinone/mitoquinol mesylate (Mito-MES) to prevent the development and progression of severe viral infections like COVID-19 after high-risk exposure to a person with possible resp...
What is the current status of trial NCT05381454?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 80 participants. The study started on 2022-04-28. Estimated completion is 2023-05-09.
What interventions are being tested in trial NCT05381454?
The interventions under investigation include: Mitoquinone/mitoquinol mesylate (DRUG).
Who is sponsoring clinical trial NCT05381454?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.